This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ABT-122
Description: ABT-122 is a dual-variable domain Ig (DVD-Ig) that targets tumor necrosis factor (TNF) and interleukin 17 (IL-17). DVD-Ig is a proprietary Abbott technology representing an innovative approach that can target multiple disease-causing antigens with a single biologic agent.
Additional information available to subscribers only: